Company news

PureTech Health PLC news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Vedanta Appoints Drug Development Leader as CMO

September 16, 2020

Gelesis Presents Plenity Efficacy and Safety Data

September 4, 2020

Vor Appoints John King as Chief Commercial Officer

August 26, 2020

Publication of Shareholder Circular

August 26, 2020

Sonde Makes Acquisition in Vocal Biomarker Space

August 25, 2020

PureTech to Present at Wedbush PacGrow Conference

August 5, 2020

Vor Appoints Life Science Leader to BOD

July 30, 2020

Vor Appoints Biotech Finance Leader to BOD

July 16, 2020

Vor Names Oncology Drug Development Expert as CMO

July 14, 2020

Sonde Launches Voice Health Screening for COVID-19

July 8, 2020

PureTech's Vor Raises $110M Series B Financing

July 7, 2020

Karuna Positive FDA End of Phase 2 Meeting

June 23, 2020

Akili Gets European Approval to Market EndeavorRx

June 23, 2020

PRTC Presents New Immuno-oncology Data at AACR

June 22, 2020

Gelesis China Deal $35M and up to $388M milestones

June 18, 2020

Akili Granted FDA Clearance for ADHD Treatment

June 16, 2020

Positive Data from Vedanta IBD Clinical Studies

June 9, 2020

Positive FDA Feedback on Follica

June 4, 2020

Gelesis Approved to Market Plenity in Europe

June 2, 2020

PRTC Targets COVID-19 Post-Recovery Complications

May 28, 2020

PRTC to Present at Jefferies Virtual Conference

May 27, 2020

Vor Appoints CFO Nathan Jorgensen

May 26, 2020

PRTC Receives Another $45M from Affiliate Shares

May 26, 2020

PDMR Notification - Transfer From Trust

May 20, 2020

Akili ADHD Treatment Now Available in US

April 22, 2020

PRTC to Present at Virtual Needham Conference

April 14, 2020

Gelesis: World's Most Innovative Companies List

March 10, 2020

Clinical Trial Initiated Of Wholly-Owned Candidate

March 3, 2020

Akili ADHD Study in The Lancet Digital Health

February 25, 2020

PureTech Receives $200M from KRTX Shares

January 23, 2020

Akili's New ADHD Trial Met Primary Endpoint

January 15, 2020

Follica Positive Androgenetic Alopecia Study

December 19, 2019

Gelesis Partners with US Telehealth Provider

December 17, 2019

Akili Meets Primary Endpoint in MDD Clinical Trial

December 12, 2019

Vedanta & BMS Begin Immuno-Oncology Clinical Study

December 10, 2019

Gelesis Attracts $84M in New Capital for Launch

December 9, 2019

Vedanta MultiDrug Resistance Program Granted $5.8M

December 5, 2019

Karuna Prices $250M Follow-On Offering

November 21, 2019

Karuna Successful Ph2 Schizophrenia Study Readout

November 18, 2019

resTORbio Update on Phase 3 Trial

November 15, 2019

PureTech to Present at Jefferies London Conference

November 13, 2019

PRTC Presents Novel Oncology Program Data at SITC

November 5, 2019

Gelesis Shares New Plenity Safety & Efficacy Data

November 5, 2019

Sonde Names Healthcare Tech Exec David Liu as CEO

October 24, 2019

Minority Stake Acquisition & PDMR Notification

October 2, 2019

Vor Appoints Senior Cell & Gene Therapy Leaders

October 1, 2019

Vedanta Expands Series C with $62.1M Total Raised

September 23, 2019

PureTech Health plc Half-Year Report

August 27, 2019

Vor Names Biotech Vet Robert Ang President & CEO

August 7, 2019

Vor Biopharma Adds R&D Leader Bill Lundberg to BOD

July 31, 2019

← Newer news releases · Older news releases →

Calls

The 5 newest of 6 calls. Every call is listed under its year.

Decks

The 5 newest of 7 decks. Every deck is listed under its year.